CSIMarket
 
Artivion Inc   (NYSE: AORT)
 
Price: $24.5500 $-0.67 -2.657%
Day's High: $25.329999923706055 Week Perf: -4.18 %
Day's Low: $ 24.55 30 Day Perf: -13.53 %
Volume (M): 171,651 52 Wk High: $ 48.25
Volume (M$): $ 0 52 Wk Avg: $35.49
Open: $25.12 52 Wk Low: $19.16



 Market Capitalization (Millions $) 1,221
 Shares Outstanding (Millions) 50
 Employees 1,800
 Revenues (TTM) (Millions $) 458
 Net Income (TTM) (Millions $) 12
 Cash Flow (TTM) (Millions $) 18
 Capital Exp. (TTM) (Millions $) 43

Business Description


Artivion Inc is a technology company based in San Francisco, California, that focuses on providing solutions for the healthcare industry using emerging technologies such as artificial intelligence and machine learning. The company was founded in 2018 by a team of former Google employees and healthcare professionals.

Artivion's mission is to bring revolutionary advancements in healthcare by leveraging the power of data and artificial intelligence. The company is dedicated to creating innovative and cost-effective healthcare solutions that improve patient outcomes and drive efficiency in healthcare operations.

Artivion's flagship product is the Clinical Intent Engine (CIE), an AI-driven platform that helps healthcare professionals to quickly and accurately analyze medical records, identify clinical insights, and make informed decisions based on the available data. CIE is designed to integrate with existing electronic health records (EHR) systems and helps to identify patient risk factors, understand treatment options, and monitor outcomes.

In addition to the CIE platform, Artivion offers consulting services to healthcare organizations to help them optimize their workflows and improve their operations. The company also collaborates with leading academic institutions and healthcare organizations to develop cutting-edge solutions for the industry.

One of Artivion's key strengths is its team of experts in healthcare and artificial intelligence. The company's leadership includes experienced healthcare professionals, including physicians and clinical researchers, as well as experts in AI and machine learning. This combination of knowledge and expertise allows Artivion to develop solutions that are both clinically relevant and technologically advanced.

Overall, Artivion's focus on healthcare, advanced technology, and data-driven solutions positions the company well for growth and impact in the industry.


   Company Address: 1655 Roberts Boulevard, NW Kennesaw 30144 GA
   Company Phone Number: 419-3355   Stock Exchange / Ticker: NYSE AORT


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BAX   -5.7%    
BSX   -8.76%    
EW   -4.72%    
IART   -6.96%    
MDT   -0.24%    
PEN   -1.31%    
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 102.29
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 2.67
Price to Sales (Expected) -
Price to Book 2.71
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.6
Working Capital Ratio 3.86
Leverage Ratio (MRQ) 0.96
Total Debt to Equity 0.48
Interest Coverage (TTM) -
Debt Coverage (TTM) 0.19

Per Share Current
Earnings (TTM) 0.24 $
Revenues (TTM) 9.21 $
Cash Flow (TTM) 0.36 $
Cash 1.12 $
Book Value 9.06 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 254,499
Net Income per Employee (TTM) 6,494
Receivable Turnover Ratio (TTM) 5.07
Inventory Turnover Ratio (TTM) 1.76
Asset Turnover Ratio (TTM) 0.53

Profitability Ratios Current
Gross Margin (MRQ) 65.35 %
Operating Margin (MRQ) 5.01 %
Net Margin (MRQ) 1.23 %
Net Cash Flow Margin (MRQ) -7.92 %
Effective Tax Rate (TTM) 32.87 %

Management Effectiveness Current
Return On Assets (TTM) 1.35 %
Return On Investment (TTM) 1.5 %
Return On Equity (TTM) 2.66 %
Dividend Yield -
Pay out Ratio (TTM) -



Artivion Inc's Segments
North America    104.83 % of total Revenue
EMEA    38.1 % of total Revenue
APAC    7.53 % of total Revenue
LATAM    4.3 % of total Revenue
Medical devices    165.74 % of total Revenue
Preservation services    43.96 % of total Revenue
Products    78.66 % of total Revenue
Aortic stent grafts    38.46 % of total Revenue
On-X    22.48 % of total Revenue
Surgical sealants    32.99 % of total Revenue
Other    1.98 % of total Revenue
Europe, the Middle East, and Africa    76.69 % of total Revenue
Asia Pacific    18.07 % of total Revenue
Latin America    10.11 % of total Revenue
On X    48.9 % of total Revenue
Other Products    5.19 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.